Ubs Group Ag Adial Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.24 - $0.56 $2,742 - $6,398	-11,425 Reduced 51.8%	10,630 $3,000
Q4 2022 Feb 08, 2023	SELL	$0.2 - $9.25 $2,692 - $124,523	-13,462 Reduced 37.9%	22,055 $4,000
Q3 2022 Nov 10, 2022	BUY	$0.03 - $46.0 $1,065 - $1.63 Million	35,517 New	35,517 $12,000
Q2 2022 Aug 10, 2022	SELL	$28.0 - $53.25 $191,520 - $364,230	-6,840 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$45.0 - $69.0 $144,720 - $221,904	3,216 Added 88.74%	6,840 $14,000
Q4 2021 Feb 14, 2022	SELL	$62.25 - $104.5 $47,683 - $80,047	-766 Reduced 17.45%	3,624 $10,000
Q3 2021 Nov 15, 2021	BUY	$57.75 - $116.75 $253,522 - $512,532	4,390 New	4,390 $19,000
Q2 2021 Aug 13, 2021	SELL	$50.5 - $78.25 $224,573 - $347,977	-4,447 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$43.25 - $79.75 $288,564 - $532,092	-6,672 Reduced 60.01%	4,447 $11,000
Q4 2020 Feb 11, 2021	BUY	$42.25 - $58.25 $413,965 - $570,733	9,798 Added 741.71%	11,119 $19,000
Q3 2020 Nov 12, 2020	BUY	$30.25 - $75.75 $39,960 - $100,065	1,321 New	1,321 $3,000
Q3 2019 Nov 14, 2019	SELL	$36.0 - $42.0 $60,912 - $71,064	-1,692 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	N/A	-2,099 Reduced 55.37%	1,692 $3,000
Q1 2019 May 14, 2019	BUY	N/A	1,068 Added 39.22%	3,791 $13,000
Q4 2018 Feb 14, 2019	BUY	N/A	2,165 Added 387.99%	2,723 $14,000
Q3 2018 Nov 14, 2018	BUY	N/A	558 New	558 $2,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.